Status:
COMPLETED
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retr...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia.
- At least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 - 30th of September 2010).
- Hospitalization due to psychotic symptoms at any time during the study period (1st of July 2009 - 30th of September 2010) and with admission and discharge dates available.
Exclusion
- Participation in a clinical trial during the study period.
- Treatment in forensic care according to LRV ("Lagen om Rättspsykiatrisk Vård").
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01214135
Start Date
October 1 2010
End Date
December 1 2010
Last Update
January 11 2011
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Falköping, Sweden
2
Research Site
Gothenburg, Sweden
3
Research Site
Helsingborg, Sweden
4
Research Site
Karlskrona, Sweden